2021 annual financial data
Silence Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 73.99%.
Operating income was -45,814,000 GBP and net income was -39,410,000 GBP.
Operating cash flow was 9,185,629 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,415,000 GBP
- Operating income
- -45,814,000 GBP
- Net income
- -39,410,000 GBP
- Operating cash flow
- 9,185,629 GBP